Nutritional support of pediatric patients with cancer consuming an enteral formula with fructooligosaccharides

Nutrition Research

Volumn 26, Issue 4, 2006, Pages 154-162

  Zheng, Shan ^a   Steenhout, Philippe ^b   Kuiran, Dong ^a   Qihong, Wang ^a   Weiping, Wang ^a   Hager, Corinne ^b   Haschke, Ferdinand ^b   Clemens, Roger A ^c  

^a FUDAN UNIVERSITY   (China)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bifidobacteria; Cancer; Fructooligosaccharides; Tolerance

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; OROSOMUCOID; PREBIOTIC AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANTHROPOMETRY; ARTICLE; ARTIFICIAL MILK; BACTERIAL COUNT; BIFIDOBACTERIUM; CALORIC INTAKE; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FECES ANALYSIS; FECES MICROFLORA; FLATULENCE; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NAUSEA; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE;

EID: 33744786252     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.04.001     Document Type: Article

References (36)

1. Andreyev H.J., Norman A.R., Oates J., and Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 34 (1998) 503-509
2. ReyFerro M., Castano R., Orozco O., Serna A., and Moreno A. Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition 13 (1997) 878-881
3. Hochwald S.N., Harrison L.E., Heslin M.J., Burt M.E., and Brennan M.F. Early postoperative enteral feeding improves whole body protein kinetics in upper gastrointestinal cancer patients. Am J Surg 174 (1997) 325-330
4. Bachmann P., Gordiani B., Ranchere J.-Y., Lallemand Y., Combret D., Latour J.-F., et al. Évaluation de l'indication et de la qualité de la prise en chage nutritionnelle en cancérologie médicale. Nutr Clin Métab 12 (1998) 3-11
5. Sikora S., Ribeiro U., Kane J.M., Landreneau R.J., Lembersky B., and Posner M. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. J Parenter Enteral Nutr 282 (1997) 18-21
6. Scrimshaw N.S., and San Giovanni J.P. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 66 (1997) S464-S477
7. Schattner M. Enteral nutrition support of the patient with cancer: route and role. J Clin Gastroenterol 36 (2003) 297-302
8. Gianotti L., Braga M., Vignali A., Balzano G., Zerbi A., Bisagni P., et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 132 (1997) 1222-1230
9. Georgieff M., and Tugtekin I.F. Positive role of immune nutrition on metabolism in sepsis and multi-organ failure. Kidney Int 53 (1998) S80-S83
10. Scioscia K.A., Snyderman C.H., and Wagner R. Altered serum amino acid profiles in head and neck cancer. Nutr Cancer 30 (1998) 144-147
11. Shankardass K., Chuchmach S., Chelswick K., Stefanovich C., Spurr S., Brooks J., et al. Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. J Parenter Enteral Nutr 14 (1990) 508-512
12. Liebl B.H., Fischer M.H., Van Calcar S.C., and Marlett J.A. Dietary fiber and long-term large bowel response in enterally nourished nonambulatory profoundly retarded youth. J Parenter Enteral Nutr 14 (1990) 371-375
13. Hartemink R., VanLaere K.M., and Rombouts F.M. Growth of enterobacteria on fructo-oligosaccharides. J Appl Microbiol 83 (1997) 367-374
14. Alles M.S., Katan M.B., Salemans J.M., VanLaere K.M., Gerichhausen M.J., et al. Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch-anal anastomosis. Am J Clin Nutr 66 (1997) 1286-1292
15. Roberfroid M.B. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 33 (1993) 103-148
16. Jiang T., and Savaiano D.A. Modification of colonic fermentation by bifidobacteria and pH in vitro: impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci 42 (1997) 2370-3277
17. Taber H.S., and Roberfroid M. Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr 129 (1999) 1488S-1491S
18. Taber H.S., and Roberfroid M.B. Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer 38 (2001) 1-5
19. Axford J. Glycobiology and medicine: an introduction. J R Soc Med 90 (1997) 260-264
20. Kok N., Roberfroid M., Robert A., and Delzenne N. Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76 (1996) 881-890
21. Buddington R.K., Williams C.H., Chen S.C., and Witherly S.A. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63 (1996) 709-716
22. Hague A., Diaz G.D., Hicks D.J., Krajweski S., Reed J.C., and Paraskeva C. bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however, overexpression of bcl-2 does not protect against bak-medicated apoptosis. Int J Cancer 72 (1997) 898-905
23. Hughes R., and Rowland I.R. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 22 (2001) 43-47
24. Sanders B.G., and Kline K. Nutrition, immunology and cancer: an overview. In: Longenecker J.B., Kritchevsky D., and Drezner M.K. (Eds). Nutrition and biotechnology in heart disease and cancer (1995), Springer-Verlag, New York 185-194
25. Guigoz Y., Rochat F., Perrisseau-Carrier G., Rochat I., and Schiffrin E.J. Effects of oligosaccharide on fecal flora and non-specific immune system in elderly people. Nutr Res 22 (2002) 13-25
26. Pressac M., Vignoli L., Aymard P., and Ingenbleek Y. Usefulness of a prognostic inflammatory and nutritional index in pediatric clinical practice. Clin Chim Acta 188 (1990) 129-136
27. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. CDC Growth Charts: United States. Adv Data 2000;314:1-28.
28. Taber H.S., and Roberfroid M.B. Inulin/oligofructose and anticancer therapy. Br J Nutr 87 (2002) S283-S286
29. Naidu A.S., Bidlack W.R., and Clemens R.A. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 39 (1999) 13-126
30. Kudlackova M., Andel M., Hajkova H., and Novakova J. Follow-up of burn injuries using the PINI index. Rozhl Chir 68 (1989) 595-599
31. Bartolome L.M.L., Garcia V.C., Ruiz-Echarri Z.M.P., Calvo Ruata M.L., and Baldellou V.A. Evaluation of the nutritional state in patients with congenital cardiopathy. An Esp Pediatr 35 (1991) 185-188
32. Ingenbleek Y., and Carpentier Y.A. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 55 (1985) 91-101
33. Walsh D., Mahmoud F., and Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer 11 (2003) 60-62
34. Guigoz Y., Rochat F., Perruisseau-Carrier G., Rochat I., and Schiffrin E.J. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr Res 22 (2002) 13-25
35. Saavedra J.M., and Tschernia A. Human studies with probiotics and prebiotics: clinical implications. Br J Nutr 87 (2002) S241-S246
36. Barshop B.A., Nyhan W.L., Steenhout P.H., Endres W., Tolan D.R., and Clemens R.A. Fructo-oligosaccharide tolerance in patients with hereditary fructose intolerance. A preliminary non-randomized open challenge short-term study. Nutr Res 23 (2003) 1003-1011